Zynerba Pharmaceuticals' IPO

Zynerba Pharmaceuticals raised a round of funding on August 05, 2015. Investors include Public.

Zynerba Pharmaceuticals is a clinical-stage pharmaceutical company that is dedicated to the development of innovative transdermal synthetic cannabinoid treatments for patients with high unmet medical …

Articles about Zynerba Pharmaceuticals' IPO: